Higher genetic barrier revealed in HCV GT-1b/2/4/6 subjects than GT-1a patients-a proof of concept trial of TG-2349 (furaprevir)

Authors
Category Primary study
JournalJournal of Hepatology
Year 2016
This article has no abstract
Epistemonikos ID: 52c70dbd069c1a55cfdf5bd18d3ec809d9718144
First added on: Feb 07, 2025